Brind.

Cyclerion Therapeutics, Inc. filed reports with the SEC, and MarketBeat provided stock rating data.

2 reports, 1 independent Updated Jul 1

Gone quiet

Reports: 2
Developments: 2
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Cyclerion Therapeutics, Inc. filed reports with the SEC, and MarketBeat provided stock rating data.

Who's involved

What this event is mainly about

Securities and Exchange Commission

How it developed

Newest first. Tap a step to see who reported it.

Sep 12UBS and Zacks upgraded Cyclerion Therapeutics stock rating on September 12, 2026.Sub-event
Jun 23Cyclerion Therapeutics, Inc. filed reports with the SEC.1 source
- themarketsdaily.com

Keep exploring

The entities involved

Securities and Exchange Commission
government agency of the Philippines
- BlackRock, the manager of the iShares Core MSCI EAFE ETF, has made required filings with the Securities and Exchange Commission regarding institutional holdings.Mon 16:42
- Filing required regarding institutional holdings for Schwab Emerging Markets Equity ETF and Waterford Advisors LLC with the SEC.Mon 16:38

Related events

TG Therapeutics filed reports with the Securities and Exchange Commission on June 28, 2026.Jun 28

Coverage

Newest first; wire copies grouped

Jul 1themarketsdaily.com
Jun 23themarketsdaily.com